Subclinical hyperthyroidism and the risk of developing cardiovascular disease - a systematic review

Danish Medical Journal
|November 20, 2020
PubMed

Insights

Subclinical hyperthyroidism (SH) is linked to increased risks of atrial fibrillation (AF) and heart failure (HF). However, current research does not support a connection between SH and myocardial infarction (MI) or cardiovascular mortality.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • The cardiovascular risks associated with subclinical hyperthyroidism (SH) remain a subject of ongoing debate.
  • SH is a condition characterized by suppressed thyroid-stimulating hormone levels with normal circulating thyroid hormone concentrations.

Purpose of the Study:

  • To systematically review the existing literature on the association between subclinical hyperthyroidism and major cardiovascular outcomes.
  • To evaluate the evidence linking SH to atrial fibrillation (AF), heart failure (HF), myocardial infarction (MI), and cardiovascular mortality.

Main Methods:

  • A comprehensive literature search was conducted using the PubMed database.
  • Included studies were observational, focused on SH in human subjects, and reported on outcomes such as AF, HF, MI, or cardiovascular mortality.
  • Studies published in English or Danish with euthyroid controls were selected.

Main Results:

  • A total of 33 observational studies were included in the review.
  • Evidence from 13 studies supported an association between SH and an increased risk of AF.
  • Evidence from five studies supported an association between SH and an increased risk of HF.

Conclusions:

  • The current body of evidence suggests a significant association between subclinical hyperthyroidism and increased risks of atrial fibrillation and heart failure.
  • The reviewed literature did not establish a clear association between subclinical hyperthyroidism and the risk of myocardial infarction or overall cardiovascular mortality.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
200
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
691
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
235
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
286
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
201
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
492